Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Chubb
Accenture
Healthtrust
Covington
Baxter
Daiichi Sankyo
Argus Health
Moodys

Generated: October 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,749,194

« Back to Dashboard

Which drugs does patent 7,749,194 protect, and when does it expire?


Patent 7,749,194 protects AUVI-Q and EVZIO and is included in three NDAs.

This patent has one hundred patent family members in fourteen countries.

Summary for Patent: 7,749,194

Title:Devices, systems, and methods for medicament delivery
Abstract: Certain exemplary embodiments comprise can comprise an auto-injector, which can comprise: a vial configured to store and/or contain an injectable medicament, the vial defining a vial longitudinal axis, and a housing comprising the vial. In various embodiments, the injectable medicament can be a medicine, medication, drug, pharmaceutical, prescriptive, agent, antidote, anti-venom, hormone, stimulant, vasodilator, anesthetic, and/or nutritional supplement that is substantially ready for injection.
Inventor(s): Edwards; Evan T. (Richmond, VA), Edwards; Eric S. (Richmond, VA), Licata; Mark J. (Doswell, VA)
Assignee: Intelliject, Inc. (Richmond, VA)
Application Number:10/572,148
Patent Claim Types:
see list of patent claims
Dosage form; Device; Use; Delivery;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Kaleo Inc
AUVI-Q
epinephrine
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS201739-002Aug 10, 2012BXRXYesYes► Subscribe► SubscribeY
Kaleo Inc
AUVI-Q
epinephrine
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS201739-001Aug 10, 2012BXRXYesNo► Subscribe► SubscribeY
Kaleo Inc
EVZIO
naloxone hydrochloride
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS209862-001Oct 19, 2016RXYesYes► Subscribe► SubscribeY
Kaleo Inc
EVZIO
naloxone hydrochloride
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS205787-001Apr 3, 2014DISCNYesNo► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 7,749,194

PCT Information
PCT FiledFebruary 01, 2006PCT Application Number:PCT/US2006/003415
PCT Publication Date:August 10, 2006PCT Publication Number: WO2006/083876

Non-Orange Book Patents for Patent: 7,749,194

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,932,252Medical injector simulation device► Subscribe
7,731,690Devices, systems and methods for medicament delivery► Subscribe
9,149,579Devices, systems and methods for medicament delivery► Subscribe
8,361,026Apparatus and methods for self-administration of vaccines and other medicaments► Subscribe
8,231,573Medicament delivery device having an electronic circuit system► Subscribe
8,206,360Devices, systems and methods for medicament delivery► Subscribe
8,425,462Devices, systems, and methods for medicament delivery► Subscribe
7,416,540Devices systems and methods for medicament delivery► Subscribe
9,555,191Apparatus and methods for self-administration of vaccines and other medicaments► Subscribe
8,016,788Devices, systems and methods for medicament delivery► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 7,749,194

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Poland2285360► Subscribe
New Zealand589864► Subscribe
New Zealand570731► Subscribe
New Zealand560516► Subscribe
New Zealand555256► Subscribe
Mexico2008012446► Subscribe
Mexico2007009152► Subscribe
Mexico2007005946► Subscribe
Mexico337305► Subscribe
Mexico2010012334► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Express Scripts
Baxter
Teva
Johnson and Johnson
Cipla
Chinese Patent Office
Boehringer Ingelheim
Mallinckrodt
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot